STAT

Health tech companies often flop. But this researcher’s track record suggests there’s a strategy for success

Of the 50 companies founded out of Stanford’s Biodesign center, just two have folded. Six were acquired; the rest are "alive and well." The program director shares the secrets behind…

PALO ALTO, Calif. — A series of glass cabinets lines the back wall of this Stanford building, the shelves crowded with health technologies dreamed up here. There’s a bottle of thick blue gel that helps drugs stick inside the colon, a heartbeat-tracking patch, an under-the-sheets sensor that buzzes to prevent night terrors, and a baby doll with a dozen redesigned versions of an umbilical catheter lying next to its blanket.

“My favorite thing is just looking at some of the technologies that have come out,” said Dr. Paul Yock, pointing to a low-cost substitute for the pricey ventilators found in the intensive care unit.

The shelves are a hall of fame of sorts for Yock, a cardiologist and bioengineer who runs Stanford’s

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min letti
STAT+: Pharmalittle: Hospitals Grapple With Extra Dose Of Pfizer Vaccine; FDA Panel Meets To Review Moderna Vaccine
With the Covid-19 vaccine in short supply, hospital pharmacists found themselves throwing away one in every six doses of the first vaccines distributed this week in the U.S.
STAT1 min lettiMedical
STAT+: Pharmalittle: U.S. Considers Giving Half-doses Of Moderna Vaccine; Americans May Not Get AstraZeneca Shot Until April
The U.S. government is considering giving some people half the dose of the Moderna Covid-19 vaccine in order to speed vaccinations.
STAT1 min lettiMedical
STAT+: Pharmalittle: Feds Sue Walmart Over Opioid Prescriptions; U.S. Buys More Pfizer Vaccine Doses
According to a 160-page civil complaint, Walmart knew its system for detecting suspicious prescriptions was faulty but did little to address the matter as its network of pharmacies filled millions…